Transcranial Magnetic Stimulation (TMS) is a noninvasive drug-free FDA-approved treatment for Major Depressive Disorder, also known as clinical depression. It is used in combination with traditional methods and medications. Typically, TMS is suggested when other therapies have proven ineffective.
Since the treatment is noninvasive clients:
- Are treated in the clinic and do not require sedation.
- Can hold conversations, listen to music, or enjoy a film.
- There is no downtime after each treatment enabling patients to resume their normal activities.
TMS stimulates the brain’s prefrontal cortex believed to be the region responsible for clinical depression using MRI-strength magnetic fields. This is achieved by emitting electromagnetic pulses over a period several weeks during 30-60 minute treatments. While the period each patient receives TMS is five days per week over a four-to-eight-week period, this varies depending on the person’s response.
Dr. Karl Lanoch, a psychiatrist at TMS therapy El Dorado Hills, explains that 15 million adults in the United States experience at least one major depressive disorder per year. Professionals believe twice as many people suffer from clinical depression but do not seek treatment.
Dr. Richard Bermudes founded TMS Health Solutions in 2007. He intended to redefine psychiatric treatment using a patient-centric focus. Using this model he built a successful practice that is always seeking innovative methods of helping those with mental health issues. The practice believes that it is vital to continue being accountable, credible, and transparent. Currently, there are seven locations in Northern California with plans to expand to 25.
In the late 1800s Michael Faraday, an English scientist, discovered the principles of electromagnetic induction, diamagnetism, and electrolysis. During the early 1900s, several unsuccessful attempts were made to stimulate the brain using electromagnetic induction.
By 1985 technological advances were significant enough to further the field. A group led by Anthony Barker, a medical physicist at the University of Sheffield in the United Kingdom, successfully achieved brain stimulation using TMS.
Since then TMS therapy grew to become a reliable treatment for various mental disorders including clinical depression, obsessive-compulsive disorder, and anxiety. In 2009, the FDA approved commercial usage for treating depression in the United States.